Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery

2014 ◽  
Vol 75 ◽  
pp. 129-140 ◽  
Author(s):  
Cristiane de Souza Carvalho ◽  
Nicole Daum ◽  
Claus-Michael Lehr
Keyword(s):  
Drug Delivery ◽  
In Vitro Models ◽  
Pulmonary Drug Delivery ◽  
Biological Barriers

Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models

2015 ◽  
Vol 85 ◽  
pp. 44-56 ◽  
Author(s):  
Marius Hittinger ◽  
Jenny Juntke ◽  
Stephanie Kletting ◽  
Nicole Schneider-Daum ◽  
Cristiane de Souza Carvalho ◽  
...  
Keyword(s):  
Drug Delivery ◽  
In Vitro Models ◽  
Pulmonary Drug Delivery ◽  
Safety And Efficacy ◽  
Preclinical Safety

Nanocargos: A Burgeoning Quest in Cancer Management

2020 ◽  
Vol 10 (2) ◽  
pp. 149-163
Author(s):  
Atul Jain ◽  
Teenu Sharma ◽  
Sumant Saini ◽  
Om Prakash Katare ◽  
Vandana. Soni ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Oral Delivery ◽  
Imaging Techniques ◽  
Intestinal Barrier ◽  
Oral Route ◽  
In Vitro Models ◽  
In Vitro Toxicity ◽  
Cancer Management ◽  
Surface Modified

Cancer, a complex series of diseased conditions, contributes to a significant health problem and is a leading cause of mortalities across the world. Lately, with the advent of improved diagnostics and imaging techniques, and newer advanced oral chemotherapeutics; millions of cancer affected people can lengthen their life span. Despite all the challenges associated with an active chemotherapeutic molecule like microenvironment and the intestinal barrier of the gastrointestinal tract (GIT) etc., the oral delivery remains the most acceptable route of drug administration. In this regard, nanotechnology has played a significant role in the counteracting the challenges encountered with newly developed molecules and aiding in improving their bioavailability and targetability to the tumour site, while administering through the oral route. Several literature instances document the usage of nanostructured drug delivery systems such as lipid-based, polymerbased or metallic nanomaterials to improve the efficacy of chemotherapy. Besides, sitespecific targeted surface-modified drug delivery system designed to deliver the active molecule has opened up to the newer avenues of nanotechnology. However, the issue of potential toxicity allied with nanotechnology cannot be compromised and thus, needs specific ethical regulations and guidelines. The various in vitro models have been developed to evaluate the in vitro toxicity profile which can be further correlated with the invivo model. Thus, this review provides a summarized account of the various aspects related to the role of nanotechnology in cancer therapy and various related issues thereof; that must be triumphed over to apprehend its full promise.

scholarly journals The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems

Cells ◽  
2021 ◽  
Vol 10 (12) ◽  
pp. 3295
Author(s):  
Federica Foglietta ◽  
Loredana Serpe ◽  
Roberto Canaparo
Keyword(s):  
Drug Delivery ◽  
Cancer Cell ◽  
Cell Cultures ◽  
Drug Delivery Systems ◽  
In Vitro Models ◽  
Delivery Systems ◽  
Stimuli Responsive ◽  
Cancer Models

Stimuli-responsive drug-delivery systems (DDSs) have emerged as a potential tool for applications in healthcare, mainly in the treatment of cancer where versatile nanocarriers are co-triggered by endogenous and exogenous stimuli. Two-dimensional (2D) cell cultures are the most important in vitro model used to evaluate the anticancer activity of these stimuli-responsive DDSs due to their easy manipulation and versatility. However, some limitations suggest that these in vitro models poorly predict the outcome of in vivo studies. One of the main drawbacks of 2D cell cultures is their inadequate representation of the 3D environment’s physiological complexity, which sees cells interact with each other and the extracellular matrix (ECM) according to their specific cellular organization. In this regard, 3D cancer models are a promising approach that can overcome the main shortcomings of 2D cancer cell cultures, as these in vitro models possess many peculiarities by which they mimic in vivo tumors, including physiologically relevant cell–cell and cell–ECM interactions. This is, in our opinion, even more relevant when a stimuli-responsive DDS is being investigated. In this review, we therefore report and discuss endogenous and exogenous stimuli-responsive DDSs whose effectiveness has been tested using 3D cancer cell cultures.

scholarly journals Development and In-Vitro Evaluation of Budesonide Mucoadhesive Microspherefor Pulmonary Drug Delivery

2021 ◽  
Vol 11 (2-S) ◽  
pp. 76-81
Author(s):  
Jddtadmin Journal
Keyword(s):  
Drug Delivery ◽  
Particle Size ◽  
Drug Release ◽  
Chemical Interaction ◽  
Entrapment Efficiency ◽  
Pulmonary Drug Delivery ◽  
Sustained Drug Release ◽  
In Vitro Drug Release ◽  
Drug Entrapment Efficiency

Thepurpose of the study was to develop and evaluatemucoadhesive microspheres of Budesonide for pulmonary drug delivery systemhaving prolonged residence time and sustained drug release. Microspheres were prepared by emulsificationsolvent evaporation technique using HPMC, carbopol as polymers in varying ratios. The microspheres were evaluated for its percentage yield, drug entrapment efficiency, particle size and shape, in vitro mucoadhesion study and in vitro drug release studies.The FTIR studies revealed no chemical interaction between the drug molecule and polymers and found that drug was compatible with used polymer. The mucoadhesive microspheres showed particle size, drug entrapment efficiency and yield in the ranges of148 - 164 μm, 68.0 - 85.0%and67.52 - 87.25% respectively. In vitro drug release and mucoadhesion study confirms thatformulationF5 was the best formulation as it releases 81.8 % at the end of 12 hr. in controlled manner and percentage mucoadhesion of 75.2 % after 10 hr. This confirms the developed budesonidemucoadhesive microspheres are promising for pulmonary drug delivery system.   Keywords: Budesonide, Mucoadhesion, Microspheres, Drug entrapment efficiency.

In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain

2018 ◽  
Vol 273 ◽  
pp. 108-130 ◽  
Author(s):  
Hassan Pezeshgi Modarres ◽  
Mohsen Janmaleki ◽  
Mana Novin ◽  
John Saliba ◽  
Fatima El-Hajj ◽  
...  
Keyword(s):  
Drug Delivery ◽  
In Vitro Models

scholarly journals Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing

Pharmaceutics ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 105 ◽  
Author(s):  
Sarah Stewart ◽  
Juan Domínguez-Robles ◽  
Victoria McIlorum ◽  
Elena Mancuso ◽  
Dimitrios Lamprou ◽  
...  
Keyword(s):  
Drug Delivery ◽  
3D Printing ◽  
Three Dimensional ◽  
In Vitro Models ◽  
Implant Design ◽  
The Past ◽  
Drug Delivery Devices ◽  
Potential Use ◽  
Subcutaneous Implant

Implantable drug delivery devices offer many advantages over other routes of drug delivery. Most significantly, the delivery of lower doses of drug, thus, potentially reducing side-effects and improving patient compliance. Three dimensional (3D) printing is a flexible technique, which has been subject to increasing interest in the past few years, especially in the area of medical devices. The present work focussed on the use of 3D printing as a tool to manufacture implantable drug delivery devices to deliver a range of model compounds (methylene blue, ibuprofen sodium and ibuprofen acid) in two in vitro models. Five implant designs were produced, and the release rate varied, depending on the implant design and the drug properties. Additionally, a rate controlling membrane was produced, which further prolonged the release from the produced implants, signalling the potential use of these devices for chronic conditions.

Sign in / Sign up

Export Citation Format

Share Document